Biogen Alzheimer’s Drug Will Exceed the $56,000 List Price for Many, Analysis Says

  • 📰 WSJ
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

Biogen has said its Alzheimer’s drug is priced at $56,000 a year for a typical patient. But, the drug could cost thousands more, a new analysis says, because its cost is tied to the weight of patients.

could wind up costing thousands of dollars more per patient than the company has said because of quirks in the way the therapy and others like it are packaged and paid for.

Medicare and other insurers could wind up paying $61,000 to $62,000 a patient on average depending on the dosages each needs, according toThe discrepancy stems from the way that infused drugs like the Alzheimer’s drug, named Aduhelm, are administered: based on a patient’s body weight. The heavier a patient is, the bigger dose they need, while lighter patients require lower doses. Drugmakers package and price the infused therapies by the vial, which means an infused therapy costs more if a person’s weight requires an additional vial.

In the case of Aduhelm, patients receive 10 milligrams for every kilogram of body weight, so that lighter patients use a lower dose than heavier ones.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Wouldn’t it be cheaper to just remove aluminum out of deodorants?

What? Who the hell can afford it?

Beware strange drug companies bearing gifts...

Pay up fatties

typical USA price the poor out the market. Until you guys create a national health service you are lost

For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to him RonelMoses32 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success⚖️

this is terrible news

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Reverses Broad Approval For Controversial Alzheimer’s DrugThe FDA has greatly limited who it says should be given the Alzheimer's drug Aduhelm wow
Source: Forbes - 🏆 394. / 53 Read more »

Toyota Vows To Stop Donating To GOP Lawmakers Who Objected To Biden’s WinThe carmaker has donated $56,000 to Republicans who tried to toss out President Joe Biden’s electoral votes, according to an analysis by a left-leaning group.
Source: Forbes - 🏆 394. / 53 Read more »

Toyota Vows To Stop Donating To GOP Lawmakers Who Objected To Biden’s WinThe carmaker has donated $56,000 to Republicans who tried to toss out President Joe Biden’s electoral votes, according to an analysis by a left-leaning group. About time. But I’m still never buying another ToyotaMotorCorp brand car-that includes Lexus and Subaru. good DV2021 SaveDiversityVisa GoodluckvBiden
Source: Forbes - 🏆 394. / 53 Read more »

FDA trims use of contentious Alzheimer's drug amid backlashU.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug. The Food and Drug Administration said the change is intended to address confusion among physicians and patients about who should get the drug, which has faced an intense public backlash since its approval last month. The new drug label emphasizes that the drug, Aduhelm, is appropriate for patients with early or mild Alzheimer's but has not been studied in patients with more advanced disease. They mean backlash by scientists
Source: YahooNews - 🏆 380. / 59 Read more »

Bookings surge after Covid quarantine rules relaxedAirlines say bookings increase after the government removed quarantine rules on amber-list countries.
Source: bbchealth - 🏆 143. / 63 Read more »

FDA recommends limits on use of Alzheimer's drug amid backlashA month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use.
Source: NBCNews - 🏆 10. / 86 Read more »